Niru B. Soni

1.5k total citations
17 papers, 788 citations indexed

About

Niru B. Soni is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Niru B. Soni has authored 17 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Niru B. Soni's work include Cancer, Hypoxia, and Metabolism (3 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Pneumonia and Respiratory Infections (2 papers). Niru B. Soni is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Pneumonia and Respiratory Infections (2 papers). Niru B. Soni collaborates with scholars based in United States and United Kingdom. Niru B. Soni's co-authors include Eric F. Johnson, Philip J. Merta, Lemma Kifle, Philip J. Hajduk, James T. Metz, Keith B. Glaser, Thomas D. Penning, Usha Warrior, Kent D. Stewart and Angela M. Nilius and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Niru B. Soni

17 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Niru B. Soni United States	13	488	218	203	189	65	17	788
Bainan Wu United States	22	880 1.8×	244 1.1×	118 0.6×	150 0.8×	102 1.6×	28	1.2k
Cynthia M. Shafer United States	17	542 1.1×	154 0.7×	137 0.7×	475 2.5×	60 0.9×	30	880
Ana Negri Spain	18	649 1.3×	119 0.5×	116 0.6×	146 0.8×	79 1.2×	31	1.1k
Maria Gabriella Brasca Italy	17	345 0.7×	186 0.9×	82 0.4×	276 1.5×	40 0.6×	28	663
Peter Kovar United States	19	612 1.3×	261 1.2×	142 0.7×	379 2.0×	51 0.8×	39	993
Giovanna Zinzalla United Kingdom	18	640 1.3×	229 1.1×	79 0.4×	339 1.8×	54 0.8×	31	997
Vincent Galullo United States	10	468 1.0×	182 0.8×	90 0.4×	229 1.2×	60 0.9×	10	724
Rob Howes United Kingdom	13	578 1.2×	118 0.5×	154 0.8×	420 2.2×	121 1.9×	14	1.1k
Brinton Seashore‐Ludlow Sweden	20	649 1.3×	186 0.9×	133 0.7×	298 1.6×	31 0.5×	51	1.1k
Benedict‐Tilman Berger Germany	19	590 1.2×	197 0.9×	121 0.6×	207 1.1×	30 0.5×	50	904

Countries citing papers authored by Niru B. Soni

Since Specialization

Citations

This map shows the geographic impact of Niru B. Soni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niru B. Soni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niru B. Soni more than expected).

Fields of papers citing papers by Niru B. Soni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niru B. Soni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niru B. Soni. The network helps show where Niru B. Soni may publish in the future.

Co-authorship network of co-authors of Niru B. Soni

This figure shows the co-authorship network connecting the top 25 collaborators of Niru B. Soni. A scholar is included among the top collaborators of Niru B. Soni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niru B. Soni. Niru B. Soni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Curtin, Michael L., Robin R. Frey, H. Robin Heyman, et al.. (2012). Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families. Bioorganic & Medicinal Chemistry Letters. 22(9). 3208–3212. 19 indexed citations

Woods, Keith W., Chunqiu Lai, Julie M. Miyashiro, et al.. (2012). Aminopyrimidinone Cdc7 Kinase Inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(5). 1940–1943. 18 indexed citations

Metz, James T., Eric F. Johnson, Niru B. Soni, et al.. (2011). Navigating the kinome. Nature Chemical Biology. 7(4). 200–202. 233 indexed citations

Chen, Zehan, Sujatha M. Gopalakrishnan, Niru B. Soni, et al.. (2011). 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) Induces Phosphorylation of Eukaryotic Elongation Factor-2 (eEF2). Journal of Biological Chemistry. 286(51). 43951–43958. 94 indexed citations

Liu, Xuesong, Yan Shi, David Maag, et al.. (2011). Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a Bona Fide PARP Inhibitor. Clinical Cancer Research. 18(2). 510–523. 139 indexed citations

Curtin, Michael L., Robin R. Frey, Niru B. Soni, et al.. (2011). Abstract C202: Discovery and initial characterization of the clinical compound ABT-348, a potent inhibitor of the VEGF, PDGF, and Aurora kinase families.. Molecular Cancer Therapeutics. 10(11_Supplement). C202–C202. 1 indexed citations

Pappano, William N., Paul Jung, Jonathan A. Meulbroek, et al.. (2009). Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605. BMC Cancer. 9(1). 314–314. 14 indexed citations

Tong, Yunsong, Kent D. Stewart, Sheela A. Thomas, et al.. (2008). Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: Chemistry, biological activities, and molecular modeling. Bioorganic & Medicinal Chemistry Letters. 18(19). 5206–5208. 52 indexed citations

Frey, Robin R., Michael L. Curtin, Daniel H. Albert, et al.. (2008). 7-Aminopyrazolo[1,5-a]pyrimidines as Potent Multitargeted Receptor Tyrosine Kinase Inhibitors. Journal of Medicinal Chemistry. 51(13). 3777–3787. 42 indexed citations

10.

Dai, Yujia, Niru B. Soni, Lori J. Pease, et al.. (2007). Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 386–390. 31 indexed citations

11.

Heyman, H. Robin, Robin R. Frey, Peter F. Bousquet, et al.. (2006). Thienopyridine urea inhibitors of KDR kinase. Bioorganic & Medicinal Chemistry Letters. 17(5). 1246–1249. 33 indexed citations

12.

Hinman, Mira M., Linda E. Chovan, Douglas Kalvin, et al.. (2006). Novel Antibacterial Class: A Series of Tetracyclic Derivatives. Journal of Medicinal Chemistry. 49(16). 4842–4856. 7 indexed citations

13.

Gu, Yu, Richard F. Clark, Zhenkun Ma, et al.. (2005). Design, synthesis and structure–activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae. Bioorganic & Medicinal Chemistry Letters. 15(10). 2653–2658. 12 indexed citations

14.

Stoner, Eric J., M.S. Allen, Rodger F. Henry, et al.. (2005). An Unusual Intramolecular Hetero-Diels−Alder Cycloaddition. The Journal of Organic Chemistry. 70(8). 3332–3335. 1 indexed citations

15.

Pratt, Steven, Peter J. Dandliker, Xiaoling Xuei, et al.. (2004). A Strategy for Discovery of Novel Broad-Spectrum Antibacterials Using a High-Throughput Streptococcus pneumoniae Transcription/Translation Screen. SLAS DISCOVERY. 9(1). 3–11. 22 indexed citations

16.

Beebe, Xenia, Angela M. Nilius, Philip J. Merta, et al.. (2003). Synthesis and SAR evaluation of oxadiazolopyrazines as selective Haemophilus influenzae antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 13(19). 3133–3136. 21 indexed citations

17.

Almer, Laurel S., Virginia D. Shortridge, Angela M. Nilius, et al.. (2002). Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease. 43(3). 225–232. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact